Press "Enter" to skip to content

New patent for Melinta drug BAXDELA

0
Copyright © DrugPatentWatch. Originally published at New patent for Melinta drug BAXDELA

Annual Drug Patent Expirations for BAXDELA
Annual Drug Patent Expirations for BAXDELA

Baxdela is a drug marketed by Melinta and is included in two NDAs. It is available from one supplier. There are thirteen patents protecting this drug.

Drug patent litigation for BAXDELA.

This drug has sixty-six patent family members in seventeen countries.

The generic ingredient in BAXDELA is delafloxacin meglumine. One supplier is listed for this compound. Additional details are available on the delafloxacin meglumine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Melinta drug BAXDELA
Do NOT follow this link or you will be banned from the site!